Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

NCT00002652

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Completed

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

NCT00007995

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States

View Trial Details

Completed

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

NCT00003451

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

NCT00002657

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations: MBCCOP - University of South Alabama Mobile, Alabama, United States

CCOP - Greater Phoenix Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States

Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States

View all 86 locations

View Trial Details

Completed

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

NCT00005805

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

NCT00089167

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00027560

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

NCT00003853

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

University of Pavia Pavia, Italy

View Trial Details

Completed

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

NCT00900406

Conditions: Adnexal Diseases, Blood Protein Disorders, Bone Marrow Diseases, +58 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma

NCT00012350

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions